GratXray

Description

GratXray develops breast cancer imaging technology, including senoa breast CT, combining scientific work with safer, more reliable, pain-free diagnosis for healthcare partners, women, and society.

GratXray is located in the Zurich ecosystem.

Related

• Synapsis LabsSynapsis Labs builds clinical-grade AI products for breast imaging, including Sentinel for mammography (DBT and MMG) and Nexus for breast…
• TensiveTensive develops REGENERA™/SOFTAG™ resorbable biopolymer scaffolds for natural breast reconstruction and post-lumpectomy tissue marking,…
• CiMaasCiMaas develops immunotherapy products that expand and engineer natural killer (NK) cells for adoptive cell therapy and CAR‑NK applications…
• MultiplexDXMultiplexDX develops multiplexed diagnostic tests and related molecular biology products for clinical and research customers, including…
• BOYDSenseBOYDSense develops non-invasive, pain-free health monitoring technology and devices for multi-condition detection and monitoring, with an…
• Molecular PartnersMolecular Partners develops DARPin therapeutics, including Radio-DARPins and logic-gated Switch-DARPins, to target DLL3, FAP x CD40, and…
• EndomagEndomag provides surgical guidance products for breast cancer procedures, including lesion localization and sentinel node biopsy, to help…
• Numab TherapeuticsNumab Therapeutics engineers multispecific antibodies, combining antibody engineering and Swiss scientific expertise to build a proprietary…
• Prevision MedicinePrevision Medicine tests living cancer and healthy cells from a patient biopsy against 100+ drugs and combinations using a patented ex vivo…